Oral valganciclovir: a new option for treatment of cytomegalovirus infection and disease in immunocompromised hosts (Q34481742)

2 August 2017

1 reference

title

Oral valganciclovir: a new option for treatment of cytomegalovirus infection and disease in immunocompromised hosts (English)

1 reference

2 August 2017

0 references

1 reference

cytomegaloviral disease

1 reference

P Reusser

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

Expert Opinion on Investigational Drugs

2 August 2017

published in

1 reference

2 August 2017

1 reference

2 August 2017

1 reference

2 August 2017

page(s)

1745-1753

1 reference

NIH conference. Epstein-Barr virus infections: biology, pathogenesis, and management

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1745

Human herpesvirus-6 in transplantation: an emerging pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1745

Cytomegalovirus (CMV)-specific T cell immunity after renal transplantation mediates protection from CMV disease by limiting the systemic virus load

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1745

Recent advances in varicella-zoster virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1745

Cytomegalovirus Infection in Patients with AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1745

Single-dose pharmacokinetics of valganciclovir in HIV- and CMV-seropositive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1745

Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients. The Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1745

A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1745

Prevention of cytomegalovirus disease in recipients of solid-organ transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1745

Cytomegalovirus infection following liver transplantation: review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1745

Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1745

Prophylaxis for CMV should now replace pre-emptive therapy in solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1745

A Controlled Trial of Ganciclovir to Prevent Cytomegalovirus Disease after Heart Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1745

A comparison of ganciclovir and acyclovir to prevent cytomegalovirus after lung transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1745

A prospective randomized trial comparing sequential ganciclovir-high dose acyclovir to high dose acyclovir for prevention of cytomegalovirus disease in adult liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1745

Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1745

Prophylaxis for CMV should not now replace pre-emptive therapy in solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1745

Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1745

Therapeutic developments in cytomegalovirus retinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1745

Randomized, controlled study of the safety and efficacy of intravenous cidofovir for the treatment of relapsing cytomegalovirus retinitis in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1745

Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1745

Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1745

A randomized, placebo-controlled trial of the safety and efficacy of oral ganciclovir for prophylaxis of cytomegalovirus disease in HIV-infected individuals. Terry Beirn Community Programs for Clinical Research on AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1745

A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis S

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1745

Transport of valganciclovir, a ganciclovir prodrug, via peptide transporters PEPT1 and PEPT2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1745

Preevaluation of clinical trial data: the case of preemptive cytomegalovirus therapy in patients with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1745

Long-term follow-up of patients with AIDS treated with parenteral cidofovir for cytomegalovirus retinitis: the HPMPC Peripheral Cytomegalovirus Retinitis Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.10.9.1745

10.1517/13543784.10.9.1745

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference